Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Dr. Mark Hyman Joins Levels as Advisor

International Functional Medicine Expert Partners with Levels to Solve Metabolic Health Crisis

Levels (PRNewsfoto/Levels)

News provided by

Levels

May 18, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, May 18, 2021 /PRNewswire/ -- Levels, the first biowearable system to give real-time biofeedback on nutrition and lifestyle, today announced that Dr. Mark Hyman has joined the company as an Advisor. Dr. Hyman is an internationally recognized leader, speaker, educator, and advocate in the field of Functional Medicine. He is the founder and director of The UltraWellness Center, the Head of Strategy and Innovation of the Cleveland Clinic Center for Functional Medicine, a fourteen-time New York Times best-selling author, and Board President for Clinical Affairs for The Institute for Functional Medicine. He is the host of one of the leading health podcasts, The Doctor's Farmacy. Dr. Hyman is a regular medical contributor to several television shows and networks, including CBS This Morning, Today, Good Morning America, The View, and CNN. He is also an advisor and guest co-host on The Dr. Oz Show. Dr. Hyman joins current Levels Advisors including: Gerald Shulman, MD, PhD; Ben Bikman, PhD; Dom D'Agostino, PhD; Sara Gottfried, MD; Molly Maloof, MD; and David Perlmutter, MD.

Continue Reading
Dr. Mark Hyman Joins Levels as Advisor
Dr. Mark Hyman Joins Levels as Advisor

"Dr. Mark Hyman is the preeminent pioneer in bringing the importance of metabolic health to the mainstream conversation and communicating how metabolism is the foundation of health. We are thrilled to partner with him on our shared mission to reverse the metabolic disease epidemic," said Dr. Casey Means, Co-Founder and Chief Medical Officer of Levels. "Virtually no one has had more of a positive impact on articulating and amplifying the importance of a root-cause approach to health, and his work and perspective have deeply influenced Levels from the origins of the company. Dr. Hyman has also been a trailblazer in shining a bright light on the systems issues that have contributed to the astronomical rise of chronic disease and immense social disparities in health in the US over the last several decades, including food marketing, agricultural and food policy, school lunch standards, and more. Our work together will pave the way for all people to have a greater ability to understand the impact of food and lifestyle factors on our health so that we can be empowered to make healthier choices to support our wellbeing."

Dr. Hyman agrees: "Metabolic disease is the single biggest threat to human health and prosperity in the modern world, and is largely preventable. I am thrilled to partner with Levels to empower individuals with the ability to understand and optimize their metabolic health by using real-time biofeedback to shape a personalized dietary and lifestyle plan. Stable and healthy blood sugar levels are required for good health and longevity, and Levels is revolutionizing the ability of individuals to achieve this. Living in the US, we face an uphill battle in our efforts to be truly healthy, with 88% of American adults having metabolic dysfunction, which underlies the development of obesity, diabetes, cancer, stroke, dementia, heart disease, depression, anxiety, infertility, erectile dysfunction, and more. And this is a social justice issue, with metabolic disease disproportionately affecting minorities and the poor, and the impact of suboptimal food and lifestyle decisions leading to an invisible form of oppression that is very real in the US. Personal data and deep understanding of the impact of food on our bodies allows us to rise above the systems issues that breed poor health, and Levels facilitates this in a way that has never been done before. And make no mistake, this is not just a toy for the biohacker or longevity enthusiast out there; Levels is a tool for personal empowerment that can and will help anyone have more agency and control in their quest for foundational health and thriving, and the company is committed to making this as accessible as possible."

LEVELS' SOLUTION TO THE METABOLIC HEALTH CRISIS
More than 128 million Americans have prediabetes or diabetes. Of the 34 million people with diabetes, 25% don't know they have it. Of the 88 million people with prediabetes, 90% of them don't know they have it. Levels' mission is to solve the metabolic health crisis by tracking glucose in real-time and providing granular visibility into how diet and lifestyle choices affect health.

In the same way fitness trackers quantify physical activity and exercise, Levels measures the impact of one's diet and lifestyle on metabolic health by pairing continuous glucose monitoring (CGM) technology with intelligent software. The month-long Levels program includes two 14-day CGM sensors and access to the Levels app, which provides real-time analysis on how food, exercise, and other lifestyle decisions are impacting your health. Currently in closed beta, Levels has a 120,000+ person waitlist.

ABOUT DR. MARK HYMAN
Mark Hyman, MD, has devoted his life to helping others discover optimal health and address the root causes of chronic disease through the power of Functional Medicine. Dr. Hyman is an internationally recognized leader, speaker, educator, and advocate in the fields of Functional Medicine and nutrition. He is the founder and director of The UltraWellness Center, the Head of Strategy and Innovation of the Cleveland Clinic Center for Functional Medicine, a fourteen-time New York Times best-selling author, and Board President for Clinical Affairs for The Institute for Functional Medicine. He is the host of one of the leading health podcasts, The Doctor's Farmacy. Dr. Hyman is a regular medical contributor to several television shows and networks, including CBS This Morning, Today, Good Morning America, The View, and CNN. He is also an advisor and guest co-host on The Dr. Oz Show. Through his work to change policy for the betterment of public health, Dr. Hyman has testified before the Senate Working Group on Health Care Reform on Functional Medicine. He has consulted with the surgeon general on diabetes prevention and participated in the 2009 White House Forum on Prevention and Wellness. Senator Tom Harkin of Iowa nominated Dr. Hyman for the President's Advisory Group on Prevention, Health Promotion, and Integrative and Public Health.

Additionally, Dr. Hyman has presented at the Clinton Foundation's Health Matters, Achieving Wellness in Every Generation conference and the Clinton Global Initiative, as well as with the World Economic Forum on global health issues, TEDMED and TEDx. He is the winner of the Linus Pauling Award and the Nantucket Project Award. Dr. Hyman received the Christian Book of the Year Award for his work on The Daniel Plan, a faith-based initiative that helped the Saddleback Church collectively lose 250,000 pounds that he created with Rick Warren, Dr. Mehmet Oz, and Dr. Daniel Amen. He was inducted into the Books for Better Life Hall of Fame. With Dr. Dean Ornish and Dr. Michael Roizen, Dr. Hyman crafted and helped introduce the Take Back Your Health Act of 2009 to the United States Senate, which promotes reimbursement for lifestyle treatment of chronic disease. With Tim Ryan in 2015, he helped introduce the ENRICH Act into Congress to fund nutrition in medical education. Dr. Hyman plays a substantial role in the major 2014 film Fed Up, produced by Laurie David and Katie Couric, which addresses childhood obesity. Please join him in celebrating the power of food as medicine at drhyman.com, follow him on Twitter, Facebook, and Instagram, and listen to his podcast The Doctor's Farmacy for conversations that matter around health, wellness, food, and politics.

ABOUT LEVELS HEALTH
Levels makes it easy for people to see how their diet affects both their health and their lifestyle in a quantifiable way by measuring biomarkers in real time. We are expanding access to continuous glucose monitoring and making it mainstream, focused on people looking to find their optimal diet and improve their metabolic fitness. Our customers are losing weight, optimizing exercise performance, and developing ideal versions of their dietary philosophy of choice.

Casey Means MD (Stanford), Josh Clemente (SpaceX, Hyperloop), Sam Corcos (CarDash, YC), David Flinner (Google), and Andrew Conner (Google) founded Levels to reverse the trend of metabolic dysfunction. Almost 10% of the United States is diabetic and that number is increasing at an increasing rate—88 million Americans are prediabetic and 70% will be diabetic within 10 years. We're starting with the performance and athletic market to build brand credibility and thought leadership and moving into mainstream health and wellness in 2021.

MEDIA CONTACT
Chegge Ulli
Jack Taylor PR
[email protected]
914-575-9132

SOURCE Levels

Related Links

http://levelshealth.com/

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Levels® Now Available at H-E-B, Marking a Major Milestone for the Brand

Levels® Now Available at H-E-B, Marking a Major Milestone for the Brand

Today, Levels, the protein powder that's made with nothing fake, ever, announced its debut at H-E-B, one of Texas' most trusted grocery chains....

Levels® ya está disponible en H-E-B, lo que supone un importante hito para la marca

Levels® ya está disponible en H-E-B, lo que supone un importante hito para la marca

Hoy, Levels, la proteína en polvo que se hace sin nada falso, anunció su debut en H-E-B, una de las cadenas de supermercados más confiables de Texas. ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Cosmetics and Personal Care

Cosmetics and Personal Care

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.